X

API

Morepen Laboratories Ltd Q1FY24; 150% rise in Profits

Morepen Laboratories Ltd is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical…

NGL Fine Chem Ltd Q1FY24; 1431% rise in Profits

Established in 1981, NGL Fine-Chem Limited manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical…

Vaishali Pharma Ltd Q1FY24; 5% rise in Profits

Incorporated in 1989, Vaishali Pharma Ltd. is engaged in the manufacturing, trading & marketing of Active Pharmaceutical Ingredients(APIs), pharmaceuticals formulations,…

Par Drugs & Chemicals Ltd Q1FY24; 8% rise in Profits

Par Drugs & Chemicals Ltd is primarily engaged in manufacturing of Active Pharma Ingredients (APIs) and fine chemicals for domestic…

Supriya Lifescience Ltd Q1FY24; 16% rise in Profits

Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces…

Sun Pharmaceuticals Industries Ltd Q1FY24; 4% fall in Profits

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and…

RPG Life Sciences Ltd Q1FY24; 22% rise in Profits

RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients…

Unichem Laboratories Ltd Q1FY24; 37% rise in Revenue

Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas. Financial Results: Unichem Laboratories Ltd…

Sun Pharmaceuticals Ltd Q4FY23 results out, revenue grows by 16%

Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹10,931 Crore, up from ₹9,447 Crore year on year depicting…

Suven Pharmaceuticals Ltd Q4FY23 results out, net profit grows by 35%

Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma…

Divi’s Laboratories Ltd Q4 FY23 Earnings Conference Call Insights

Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q4 FY23 Earnings Concall Q&A Highlights: [00:11:30] Tushar Manudhane from Motilal Oswal asked…

Zydus Lifescience Ltd Q4FY23 results out, revenue grows by 32%

In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From…

Solara Active Pharma Q4FY23 results out, revenue grows by 6%

Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading…

Tanla Platform Q4FY23 results out, revenue drops by 2%

Tanla Platforms Ltd (formerly Tanla Solutions Ltd) is a cloud communications provider enabling businesses to communicate with their customers and…

Laurus Labs Q3FY23 net profit rises by 32 percent

Pharmaceutical and biotechnology company Laurus Labs reported 32% year-on-year (YoY) rise in profit after tax to INR 203 crore for…

Wockhardt posted a net loss of INR 102 Crores in Q3FY23

Drugmaker Wockhardt posted a consolidated loss of ₹102 crore for the three months ended December 31, 2022. The company posted…

Lupin Q2FY23 results out: Net profit rises more than 100%

Shares of Lupin gained as much as 8 percent in early trading on Thursday after the company returned to profitability…

Divi’s Laboratories Ltd Q2 FY23 Earnings Conference Call Insights

https://youtu.be/e1-tljnhSVM Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q2 FY23 Earnings Concall Management Update: [00:06:48] DIVISLAB stated that though global…

Decoding India’s leading API development company – Dr Reddy’s Laboratories

About Company:  Founded in 1984 and headquartered in Hyderabad, India, Dr Reddy’s Laboratories (DRL) is India’s second largest pharma company…

Divi’s Laboratories Ltd Q1 FY23 Earnings Conference Call Insights

https://youtu.be/EPaxfKgyoZQ Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q1 FY23 Earnings Concall Q&A Highlights: Tushar Manudhane from Motilal Oswal asked…

Infographic: Divi’s Lab Q1 results out, Net profit rises 26%

On Friday, Pharmaceuticals company Divis Laboratories reported a 26% rise in its consolidated net profit at ₹702 crore as compared…